Propanc Biopharma (NASDAQ: PPCB) has announced plans to purchase $100 million worth of Ethereum (ETH) over the next 12 months. This move is part of the company's diversification strategy aimed at optimizing asset allocation. The biopharmaceutical firm intends to support its operations in drug development, asset acquisitions, and cryptocurrency ventures through this investment.
Propanc Biopharma to Invest $100 Million in Ethereum
Disclaimer: The content provided on Phemex News is for informational purposes only. We do not guarantee the quality, accuracy, or completeness of the information sourced from third-party articles. The content on this page does not constitute financial or investment advice. We strongly encourage you to conduct you own research and consult with a qualified financial advisor before making any investment decisions.